Evaluation of the Clinical Impact of Adjunctive L-carnitine Therapy in Critically Ill Hepatic Patients Admitted to Intensive Care Unit

Recruiting now · Phase 4

Conditions studied: Hepatic

In brief

This study aims to evaluate the possible efficacy of l-carnitine in critically ill hepatic patients admitted to intensive care unit.

Key facts

Study ID

NCT07642076

Run by

Beni-Suef University

People needed

58

Starts

2026-06-01

Expected to finish

2027-03-01

Last updated by the study team

2026-07-21

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Age more than 18 years old
• male or female with confirmed liver disease admitted to intensive care unit, including:
• Acute-on-chronic liver failure (ACLF)
• Hepatic encephalopathy
• spontaneous bacterial peritonitis (SBP)
• variceal bleeding
• fulminant hepatitis
• Hepatorenal syndrome
• Ascites
• Etc

You may not qualify if…

• Age of less than 18 years old
• Pregnancy or Lactation
• patients have seizure
• patient on warfarin

Where it is running

• National liver institute — Menoufia, Egypt (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.